Benjamin G. Keselowsky
University of Florida
H-index: 35
North America-United States
Top articles of Benjamin G. Keselowsky
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Design principles of microparticle size and immunomodulatory factor formulation dictate antigen-specific amelioration of multiple sclerosis in a mouse model | Biomaterials | Alexander J Kwiatkowski Eric Y Helm Joshua Stewart Juan Leon Theodore Drashansky | 2023/3/1 |
Targeted effector proteins and uses thereof | 2023/3/14 | ||
Bioresorbable metal alloy and implants | 2023/2/2 | ||
Self-assembling uricase fusion peptides | 2023/11/23 | ||
Biomaterials‐based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents | Journal of Biomedical Materials Research Part A | Gregory P Marshall Judit Cserny Chun‐Wei Wang Benjamin Looney Amanda L Posgai | 2023/2 |
Intra-articular delivery of an indoleamine 2, 3-dioxygenase galectin-3 fusion protein for osteoarthritis treatment in male Lewis rats | Arthritis Research & Therapy | Brittany D Partain Evelyn Bracho-Sanchez Shaheen A Farhadi Elena G Yarmola Benjamin G Keselowsky | 2023/9/18 |
Suppression of local inflammation via galectin-anchored indoleamine 2, 3-dioxygenase | Nature biomedical engineering | Evelyn Bracho-Sanchez Fernanda G Rocha Sean K Bedingfield Brittany D Partain Sabrina L Macias | 2023/9 |
Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8+ T cells | Science immunology | Eric Y Helm Tomas Zelenka Valeriu B Cismasiu Shamima Islam Leonardo Silvane | 2023/4/28 |
Galectin-Anchored indoleamine 2, 3-dioxygenase tissue-targeted therapeutic enzyme suppresses local inflammation in multiple animal models | Benjamin Keselowsky Gregory Hudalla Shannon Wallet Craig Duvall Kyle Allen | 2022 | |
Galectin-anchored indoleamine 2, 3-dioxygenase suppresses local inflammation | bioRxiv | Evelyn Bracho-Sanchez Fernanda Rocha Sean Bedingfield Brittany D Partain Maigan A Brusko | 2021/5/9 |
Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in mice | Proceedings of the National Academy of Sciences | Alexander J Kwiatkowski Eric Y Helm Joshua M Stewart Theodore T Drashansky Jonathan J Cho | 2022/10/25 |
Post-translational glycosylation of polypeptide tags for modification of protein assembly and receptor targeting | Eric Hill Alexander J Kwiatkowski Gregory Hudalla Benjamin G Keselowsky | 2022/10/31 | |
Targeted chondroitinase abc fusion proteins and complexes thereof | 2022/4/7 | ||
Perspectives on immunometabolism at the biomaterials interface | Sabrina L Macias Benjamin G Keselowsky | 2022/2/1 | |
BCL11B is positioned upstream of PLZF and RORγt to control thymic development of mucosal-associated invariant T cells and MAIT17 program | Iscience | Theodore T Drashansky Eric Y Helm Nina Curkovic Jaimee Cooper Pingyan Cheng | 2021/4/23 |
GRAS-microparticle microarrays identify dendritic cell tolerogenic marker-inducing formulations | Lab on a Chip | Matthew R Carstens Clive H Wasserfall Abhinav P Acharya Jamal Lewis Nikunj Agrawal | 2021 |
Submandibular injection of indoleamine 2, 3-dioxygenase galectin-3 fusion protein inhibits and prevents periodontal disease progression over 12 weeks | bioRxiv | Fernanda Rocha Christina Graves Ali Altitinchi Shaheen A Farhadi Sabrina L Macias | 2021/7/28 |
Microparticle systems and their use for the treatment of multiple sclerosis | 2021/6/10 | ||
Immunosuppressive PLGA TGF-β1 microparticles induce polyclonal and antigen-specific regulatory T cells for local immunomodulation of allogeneic islet transplants | Frontiers in immunology | Ying Li Anthony W Frei Irayme M Labrada Yanan Rong Jia-Pu Liang | 2021/5/27 |
Antigen-specific, tolerance-inducing microparticles and uses thereof | 2021/4/27 |